Evidence map›Paper›PMID 36077841›Full record

ArticleCancers2022

Exercise Promotes Pro-Apoptotic Ceramide Signaling in a Mouse Melanoma Model.

Jonghae Lee, Hannah Savage, Shinji Maegawa, Riccardo Ballarò, Sumedha Pareek, Bella Samia Guerrouahen, Vidya Gopalakrishnan, Keri Schadler

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jonghae LeeDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-1182-9653
Hannah SavageDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Shinji MaegawaDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Riccardo BallaròDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Sumedha PareekDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Bella Samia GuerrouahenDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Vidya GopalakrishnanDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Keri SchadlerDepartment of Pediatrics Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-1675-0514
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
RESEARCH PILOT PROJECTS PROGRAMP30GM103339 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CROSSON, CRAIG E. · 2012 to 2016
$5.4M
Functional Proteomics by Reverse Phase Protein Array in CancerR50CA221675 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LU, YILING · 2017 to 2021
$726k
CPRIT Graduate Scholars program RP170067MD Anderson Cancer Center institutional research startup funds N/ANCI NIH HHS P30 CA016672NCI NIH HHS P30 CA138313NCI NIH HHS R50 CA221675NIGMS NIH HHS P30 GM103339Pauline Altman-Goldstein Foundation Discovery Fellowship and student fellowship from the Schissler Foundation, Graduate School of Biomedical Sciences, University of Texas MD Anderson Cancer Center, N/Athe Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina NCI Grant P30CA138313 and P30GM103339the RPPA core, the University of Texas MD Anderson Cancer Center NCI Grant CA16672 and NIH R50CA221675
6 · The paper itself

Abstract

Ceramides are essential sphingolipids that mediate cell death and survival. Low ceramide content in melanoma is one mechanism of drug resistance. Thus, increasing the ceramide content in tumor cells is likely to increase their sensitivity to cytotoxic therapy. Aerobic exercise has been shown to modulate ceramide metabolism in healthy tissue, but the relationship between exercise and ceramide in tumors has not been evaluated. Here, we demonstrate that aerobic exercise causes tumor cell apoptosis and accumulation of pro-apoptotic ceramides in B16F10 but not BP melanoma models using mice. B16F10 tumor-bearing mice were treated with two weeks of moderate treadmill exercise, or were control, unexercised mice. A reverse-phase protein array was used to identify canonical p53 apoptotic signaling as a key pathway upregulated by exercise, and we demonstrate increased apoptosis in tumors from exercised mice. Consistent with this finding, pro-apoptotic C16-ceramide, and the ceramide generating enzyme ceramide synthase 6 (CerS6), were higher in B16F10 tumors from exercised mice, while pro-survival sphingosine kinase 1 (Sphk1) was lower. These data suggest that exercise contributes to B16F10 tumor cell death, possibly by modulating ceramide metabolism toward a pro-apoptotic ceramide/sphingosine-1-phosphate balance. However, these results are not consistent in BP tumors, demonstrating that exercise can have different effects on tumors of different patient or mouse origin with the same diagnosis. This work indicates that exercise might be most effective as a therapeutic adjuvant with therapies that kill tumor cells in a ceramide-dependent manner.

Indexed as

cell deathCerS6physical activityskin cancersphingolipid metabolism

Identifiers

PMID36077841
PMCPMC9454537
OpenAlexW4294862407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.